Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The liver is the primary target of hepatitis C virus (HCV) infection. However, HCV RNA and protein are often observed to associate with B cells and other blood cells. Are these cells truly infected, and if so, does the infection lead to B cell abnormalities? Not all investigators agree. This chapter discusses our recommendations for a rigorous evaluation of the potential roles of blood cells as sites of HCV infection. The detection of HCV RNA and protein should be combined with evaluations of whether levels of these markers are sensitive to potent antiviral compounds that block HCV infection in liver cells. RNA quantitation should include documentation of sensitivity and specificity as well as a number of critical controls. Similarly, reports of protein detection should include documentation of the specificity of the antibodies used, and particularly of the frequency of antigen-positive cells relative to the number of HCV genomes detected. B cells, like other blood cells, do not express all of the cellular factors believed to be required for HCV entry or productive infection. Thus, a number of significant questions must be addressed before we understand whether, and how, infection of B cells contributes to the pathogenesis of mixed cryoglobulinemia.



Book title

HCV Infection and Cryoglobulinemia



Publication Date



55 - 62

Total pages